188 related articles for article (PubMed ID: 19369417)
1. LKB1 catalytic activity contributes to estrogen receptor alpha signaling.
Nath-Sain S; Marignani PA
Mol Biol Cell; 2009 Jun; 20(11):2785-95. PubMed ID: 19369417
[TBL] [Abstract][Full Text] [Related]
2. Liver kinase B1 expression (LKB1) is repressed by estrogen receptor alpha (ERα) in MCF-7 human breast cancer cells.
Linher-Melville K; Zantinge S; Singh G
Biochem Biophys Res Commun; 2012 Jan; 417(3):1063-8. PubMed ID: 22226967
[TBL] [Abstract][Full Text] [Related]
3. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
[TBL] [Abstract][Full Text] [Related]
4. The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.
Popov VM; Zhou J; Shirley LA; Quong J; Yeow WS; Wright JA; Wu K; Rui H; Vadlamudi RK; Jiang J; Kumar R; Wang C; Pestell RG
Cancer Res; 2009 Jul; 69(14):5752-60. PubMed ID: 19605405
[TBL] [Abstract][Full Text] [Related]
5. SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.
Band AM; Laiho M
Cell Signal; 2012 Apr; 24(4):922-30. PubMed ID: 22227247
[TBL] [Abstract][Full Text] [Related]
6. Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling.
Lin-Marq N; Borel C; Antonarakis SE
Mol Genet Genomics; 2005 Apr; 273(2):184-96. PubMed ID: 15731909
[TBL] [Abstract][Full Text] [Related]
7. Human glutathione S-transferase P1-1 functions as an estrogen receptor α signaling modulator.
Liu X; An BH; Kim MJ; Park JH; Kang YS; Chang M
Biochem Biophys Res Commun; 2014 Sep; 452(3):840-4. PubMed ID: 25218501
[TBL] [Abstract][Full Text] [Related]
8. Estrogenic compound attenuates angiotensin II-induced vascular smooth muscle cell proliferation through interaction between LKB1 and estrogen receptor α.
Kim SA; Lee KY; Kim JR; Choi HC
J Pharmacol Sci; 2016 Sep; 132(1):78-85. PubMed ID: 27665370
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
Bonofiglio D; Gabriele S; Aquila S; Catalano S; Gentile M; Middea E; Giordano F; Andò S
Clin Cancer Res; 2005 Sep; 11(17):6139-47. PubMed ID: 16144913
[TBL] [Abstract][Full Text] [Related]
10. The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression.
Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J
Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816
[TBL] [Abstract][Full Text] [Related]
11. LKB1 catalytically deficient mutants enhance cyclin D1 expression.
Scott KD; Nath-Sain S; Agnew MD; Marignani PA
Cancer Res; 2007 Jun; 67(12):5622-7. PubMed ID: 17575127
[TBL] [Abstract][Full Text] [Related]
12. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
[TBL] [Abstract][Full Text] [Related]
13. The pure estrogen receptor antagonist ICI 182,780 promotes a novel interaction of estrogen receptor-alpha with the 3',5'-cyclic adenosine monophosphate response element-binding protein-binding protein/p300 coactivators.
Jaber BM; Gao T; Huang L; Karmakar S; Smith CL
Mol Endocrinol; 2006 Nov; 20(11):2695-710. PubMed ID: 16840538
[TBL] [Abstract][Full Text] [Related]
14. Functional significance of Aurora kinase A regulatory interactions with p53-ERα complex in human breast cancer cells.
Katayama H; Sen S
Horm Cancer; 2011 Apr; 2(2):117-24. PubMed ID: 21761334
[TBL] [Abstract][Full Text] [Related]
15. LKB1 when associated with methylatedERα is a marker of bad prognosis in breast cancer.
Bouchekioua-Bouzaghou K; Poulard C; Rambaud J; Lavergne E; Hussein N; Billaud M; Bachelot T; Chabaud S; Mader S; Dayan G; Treilleux I; Corbo L; Le Romancer M
Int J Cancer; 2014 Sep; 135(6):1307-18. PubMed ID: 24615515
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of LKB1/STK11 mutants and two aberrant isoforms found in Peutz-Jeghers Syndrome patients.
Boudeau J; Kieloch A; Alessi DR; Stella A; Guanti G; Resta N
Hum Mutat; 2003 Feb; 21(2):172. PubMed ID: 12552571
[TBL] [Abstract][Full Text] [Related]
17. LKB1 expression is inhibited by estradiol-17β in MCF-7 cells.
Brown KA; McInnes KJ; Takagi K; Ono K; Hunger NI; Wang L; Sasano H; Simpson ER
J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):439-43. PubMed ID: 21689749
[TBL] [Abstract][Full Text] [Related]
18. mTORC1 directly phosphorylates and activates ERα upon estrogen stimulation.
Alayev A; Salamon RS; Berger SM; Schwartz NS; Cuesta R; Snyder RB; Holz MK
Oncogene; 2016 Jul; 35(27):3535-43. PubMed ID: 26522726
[TBL] [Abstract][Full Text] [Related]
19. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.
Hao L; Rizzo P; Osipo C; Pannuti A; Wyatt D; Cheung LW; Sonenshein G; Osborne BA; Miele L
Oncogene; 2010 Jan; 29(2):201-13. PubMed ID: 19838210
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
